• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    BetterInvesting™ Magazine Update on Broadridge Financial Resources Inc. (NYSE:BR) and ResMed Inc. (NYSE:RMD)

    7/21/26 4:40:00 PM ET
    $BR
    $RMD
    Real Estate
    Real Estate
    Medical/Dental Instruments
    Health Care
    Get the next $BR alert in real time by email

    TROY, Mich., July 21, 2026 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Broadridge Financial Resources Inc.(NYSE:BR) as its "Stock to Study" and ResMed Inc. (NYSE:RMD) as its "Undervalued Stock" in the October 2026 issue for investors' informational and educational use.

    To help you along your way, BetterInvesting has a number of free resources including: https://www.betterinvesting.org/learn-about-investing/investor-education/college-saving/investment-strategies-in-saving-for-college

    For a free lesson on 6 steps to successful investing, visit https://www.betterinvesting.org/learn-about-investing/investor-education/getting-started-with-stocks/6-steps-for-successful-stock-investing

    To become a member and learn more about the principles of the National Association of Investors, visit https://www.betterinvesting.org/about-us/mission-method-of-stock-investing

    Check the October 2026 issue of BetterInvesting Magazine for more details about the latest stocks. Non-members can utilize the limited, trial version of the BetterInvesting online stock selection and analysis tools to study the investment potential of Broadridge Financial and ResMed by viewing their fundamental data and applying judgments.

    Committee members are Dan Rutter, CFA; Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; and Anne Nichols, CFA.

    As stated, the BetterInvesting committee's Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases.  Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.

    About BetterInvesting:

    BetterInvesting™, a national 501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors™ (NAIC®), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting provides unbiased, in-depth investing education and powerful online stock analysis tools to create successful lifelong investors. BetterInvesting staff, along with a dedicated community of volunteers across America, teach the organization's principles and time-tested methodology to individuals and investment clubs. For more information about BetterInvesting, please visit www.betterinvesting.org

    Follow us on LinkedIn and Facebook.

    BetterInvesting 248-583-6242

    Cision View original content:https://www.prnewswire.com/news-releases/betterinvesting-magazine-update-on-broadridge-financial-resources-inc-nysebr-and-resmed-inc-nysermd-302831312.html

    SOURCE NAIC-BetterInvesting

    Get the next $BR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BR
    $RMD

    CompanyDatePrice TargetRatingAnalyst
    ResMed Inc.
    $RMD
    7/16/2026$234.00Outperform → Sector Perform
    RBC Capital Mkts
    ResMed Inc.
    $RMD
    7/13/2026$235.00Buy → Neutral
    Citigroup
    ResMed Inc.
    $RMD
    6/17/2026$230.00Overweight → Equal-Weight
    Morgan Stanley
    ResMed Inc.
    $RMD
    4/15/2026Overweight
    Analyst
    Broadridge Financial Solutions Inc.
    $BR
    2/4/2026$228.00Neutral → Buy
    DA Davidson
    ResMed Inc.
    $RMD
    12/16/2025$275.00Outperform → Neutral
    Robert W. Baird
    ResMed Inc.
    $RMD
    9/18/2025$330.00Buy
    Citigroup
    ResMed Inc.
    $RMD
    9/2/2025Hold → Outperform
    CLSA
    More analyst ratings

    $BR
    $RMD
    SEC Filings

    View All

    ResMed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

    8-K - RESMED INC (0000943819) (Filer)

    7/7/26 5:24:32 PM ET
    $RMD
    Medical/Dental Instruments
    Health Care

    SEC Form 144 filed by ResMed Inc.

    144 - RESMED INC (0000943819) (Subject)

    7/7/26 10:07:44 AM ET
    $RMD
    Medical/Dental Instruments
    Health Care

    Broadridge Financial Solutions Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - BROADRIDGE FINANCIAL SOLUTIONS, INC. (0001383312) (Filer)

    6/10/26 4:30:23 PM ET
    $BR
    Real Estate

    $BR
    $RMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BetterInvesting™ Magazine Update on Broadridge Financial Resources Inc. (NYSE:BR) and ResMed Inc. (NYSE:RMD)

    TROY, Mich., July 21, 2026 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Broadridge Financial Resources Inc.(NYSE:BR) as its "Stock to Study" and ResMed Inc. (NYSE:RMD) as its "Undervalued Stock" in the October 2026 issue for investors' informational and educational use. To help you along your way, BetterInvesting has a number of free resources including: https://www.betterinvesting.org/learn-about-investing/investor-education/college-saving/investment-strategies-in-saving-for-collegeFor a free lesson on 6 steps to successful investing, visit https://www.betterinvesting.org/learn-about-investing/investor-education/getting-s

    7/21/26 4:40:00 PM ET
    $BR
    $RMD
    Real Estate
    Medical/Dental Instruments
    Health Care

    Broadridge Schedules Webcast and Conference Call to Review Fourth Quarter and Fiscal Year 2026 Results on August 4, 2026

    NEW YORK, July 21, 2026 /PRNewswire/ -- Broadridge Financial Solutions, Inc. (NYSE:BR) is scheduled to release its financial results for the fourth quarter and fiscal year 2026 on Tuesday, August 4, 2026. Broadridge will host a webcast and conference call to discuss those results at 8:30 a.m. ET on August 4, 2026. Tim Gokey, Chief Executive Officer, and Ashima Ghei, Chief Financial Officer, will participate on the call. To listen to the live event and access the slide presentation, visit Broadridge's Investor Relations website at www.broadridge-ir.com prior to the start of the webcast. To listen to the call, investors may also dial 1-877-328-2502 within the United States and international ca

    7/21/26 7:30:00 AM ET
    $BR
    Real Estate

    Alpaca and Broadridge Announce Governance Solution for Tokenized Securities

    Broadridge enables proxy voting, investor communications, and voting entitlement reconciliation across Alpaca's platformNEW YORK, July 20, 2026 /PRNewswire/ -- Alpaca, a global leader in agent-first brokerage infrastructure, and global Fintech leader, Broadridge Financial Solutions Inc., (NYSE:BR), today announced the integration of Broadridge's governance infrastructure for retail and institutional investors into Alpaca's Instant Tokenization Network. The partnership brings shareholder governance capabilities including proxy voting, investor communications, voting entitlement reconciliation, and regulatory disclosures across traditional and tokenized equities, helping investors retain the r

    7/20/26 6:00:00 AM ET
    $BR
    Real Estate

    $BR
    $RMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,090,771 worth of ResMed Common Stock (4,991 units at $218.55) as part of a pre-agreed trading plan (SEC Form 4)

    4 - RESMED INC (0000943819) (Issuer)

    7/9/26 7:40:12 AM ET
    $RMD
    Medical/Dental Instruments
    Health Care

    Director Nazareth Annette L. was granted 39 shares, increasing direct ownership by 0.41% to 9,614 units (SEC Form 4)

    4 - BROADRIDGE FINANCIAL SOLUTIONS, INC. (0001383312) (Issuer)

    7/6/26 12:29:06 PM ET
    $BR
    Real Estate

    Director Zavery Amit was granted 60 shares, increasing direct ownership by 0.67% to 9,011 units (SEC Form 4)

    4 - BROADRIDGE FINANCIAL SOLUTIONS, INC. (0001383312) (Issuer)

    7/6/26 12:29:04 PM ET
    $BR
    Real Estate

    $BR
    $RMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Gokey Timothy C bought $1,030,794 worth of shares (5,300 units at $194.49), increasing direct ownership by 4% to 142,876 units (SEC Form 4)

    4 - BROADRIDGE FINANCIAL SOLUTIONS, INC. (0001383312) (Issuer)

    3/9/26 7:40:16 PM ET
    $BR
    Real Estate

    $BR
    $RMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    ResMed downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded ResMed from Outperform to Sector Perform and set a new price target of $234.00

    7/16/26 8:47:08 AM ET
    $RMD
    Medical/Dental Instruments
    Health Care

    ResMed downgraded by Citigroup with a new price target

    Citigroup downgraded ResMed from Buy to Neutral and set a new price target of $235.00

    7/13/26 9:02:22 AM ET
    $RMD
    Medical/Dental Instruments
    Health Care

    ResMed downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded ResMed from Overweight to Equal-Weight and set a new price target of $230.00

    6/17/26 8:14:45 AM ET
    $RMD
    Medical/Dental Instruments
    Health Care

    $BR
    $RMD
    Leadership Updates

    Live Leadership Updates

    View All

    Broadridge Appoints Todd Diganci to its Board of Directors

    NEW YORK, June 9, 2026 /PRNewswire/ -- Broadridge Financial Solutions, Inc. (NYSE:BR), a global Fintech leader, is pleased to announce the appointment of Todd Diganci as a member of its Board of Directors, effective August 1, 2026. Following his appointment, Broadridge's expanded Board will consist of 10 members, eight of whom are independent. Mr. Diganci will serve on the Audit Committee of the Board."I am thrilled to welcome Todd, who is an accomplished financial executive with expertise in the securities industry. As the financial services industry continues to transform, his expertise will help ensure that Broadridge remains at the forefront of innovation as we continue to provide the in

    6/9/26 4:54:00 PM ET
    $BR
    Real Estate

    Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor

    SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE:RMD, ASX: RMD)), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced that Brett Sandercock, Chief Financial Officer, plans to retire effective May 4, 2026. After conducting a comprehensive search, Aaron Bloomer has been appointed as his successor.  "After 27 years with Resmed, including 20 as CFO, Brett leaves an outstanding legacy of disciplined leadership and trusted partnership," said Mick Farrell, Chairman and CEO of Resmed. "Brett's leadership has helped guide Resmed through significant growth and transformation, while keeping a clear focus on long-term value creat

    4/30/26 4:10:00 PM ET
    $RMD
    Medical/Dental Instruments
    Health Care

    Broadridge Appoints Allen Weinberg as Chief Growth and Strategy Officer

    NEW YORK, March 5, 2026 /PRNewswire/ -- Broadridge Financial Solutions, Inc. (NYSE:BR), a global Fintech leader, is pleased to announce the appointment of Allen Weinberg as Chief Growth and Strategy Officer, effective immediately. In this newly created role, Weinberg will work closely with the leadership team to implement Broadridge's strategic priorities focused on accelerating sustainable growth, enhancing profitability, and strengthening competitive differentiation. He will also help identify and evaluate new markets and product opportunities, ensuring the company's strategy remains aligned with the industry's rapidly changing landscape. Weinberg will join Broadridge's Executive Leadershi

    3/5/26 6:30:00 AM ET
    $BR
    Real Estate

    $BR
    $RMD
    Financials

    Live finance-specific insights

    View All

    Broadridge Schedules Webcast and Conference Call to Review Fourth Quarter and Fiscal Year 2026 Results on August 4, 2026

    NEW YORK, July 21, 2026 /PRNewswire/ -- Broadridge Financial Solutions, Inc. (NYSE:BR) is scheduled to release its financial results for the fourth quarter and fiscal year 2026 on Tuesday, August 4, 2026. Broadridge will host a webcast and conference call to discuss those results at 8:30 a.m. ET on August 4, 2026. Tim Gokey, Chief Executive Officer, and Ashima Ghei, Chief Financial Officer, will participate on the call. To listen to the live event and access the slide presentation, visit Broadridge's Investor Relations website at www.broadridge-ir.com prior to the start of the webcast. To listen to the call, investors may also dial 1-877-328-2502 within the United States and international ca

    7/21/26 7:30:00 AM ET
    $BR
    Real Estate

    Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026

    SAN DIEGO, June 30, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE:RMD, ASX: RMD)) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2026 on Thursday, August 6, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Location:         https://investor.resmed.comDate:               Thursday, August 6, 2026Time:               1:30 p.m. PT / 4:30 p.m. ETInternational:   London, Thursday, August 6, 2026, 9:30 p.m. BST                        Sydney, Friday

    6/30/26 4:30:00 PM ET
    $RMD
    Medical/Dental Instruments
    Health Care

    Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million

    Noctrix Health acquisition validates Angelini Ventures' strategy of investing in innovative healthcare companies addressing significant unmet medical needs and advancing connected health Rome, Italy, 3rd June 2026 – Angelini Ventures, the corporate venture firm of Angelini Industries focused on investing in companies developing innovative solutions in BioTech and HealthTech, announces that portfolio company Noctrix Health has been acquired by ResMed (NYSE:RMD), a global leader in sleep health and respiratory care, in a transaction valued at $340 million. The transaction further strengthens Angelini Ventures' mission to support the next generation of healthcare innovators, combining capit

    6/3/26 7:40:36 AM ET
    $RMD
    Medical/Dental Instruments
    Health Care

    $BR
    $RMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Broadridge Financial Solutions Inc. (Amendment)

    SC 13G/A - BROADRIDGE FINANCIAL SOLUTIONS, INC. (0001383312) (Subject)

    2/13/24 5:00:53 PM ET
    $BR
    Real Estate

    SEC Form SC 13G/A filed by Broadridge Financial Solutions Inc. (Amendment)

    SC 13G/A - BROADRIDGE FINANCIAL SOLUTIONS, INC. (0001383312) (Subject)

    1/25/24 4:59:27 PM ET
    $BR
    Real Estate

    SEC Form SC 13G/A filed by Broadridge Financial Solutions Inc. (Amendment)

    SC 13G/A - BROADRIDGE FINANCIAL SOLUTIONS, INC. (0001383312) (Subject)

    12/11/23 4:28:27 PM ET
    $BR
    Real Estate